Elsevier Inc.

SHERPA: Unknown

People

  1. Papanicolaou
    Papanicolaou
  2. Giralt
    Giralt
  3. Jakubowski
    Jakubowski
  4. Perales
    Perales
  5. Papadopoulos
    Papadopoulos
  6. Lee
    Lee
  7. Devlin
    Devlin
  8. Castro-Malaspina
    Castro-Malaspina
  9. Dahi
    Dahi
  10. Politikos
    Politikos

Groups

  1. Center for Hematologic Malignancies (25)
  2. Department of Medicine (25)
  3. Division of Subspecialty Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Infectious Disease (25)
  6. Bone Marrow Transplant (24)
  7. Survivorship Research (19)
  8. DigITs Research Group (9)
  9. CTCR Scholars (8)
  10. Sloan Kettering Institute Postdocs (8)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Meeting abstract"
  3. "Genovefa Papanicolaou"
Formats
  1. Meeting Abstract (25)
Groups
  1. Center for Hematologic Malignancies (25)
  2. Department of Medicine (25)
  3. Division of Subspecialty Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Infectious Disease (25)
  6. Bone Marrow Transplant (24)

More Groups

People
  1. Genovefa Papanicolaou (25)
  2. Ann Jakubowski (16)
  3. Sergio Giralt (16)
  4. Miguel-Angel Perales (12)
  5. Esperanza Papadopoulos (9)
  6. Juliet Barker (9)

More People

Years
  1. 2022 (2)
  2. 2020 (2)
  3. 2019 (4)
  4. 2018 (3)
  5. 2017 (1)
  6. 2016 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (22)
  2. Transplantation and Cellular Therapy (2)
  3. Blood Cells, Molecules, and Diseases (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extended letermovir prophylaxis is highly effective cytomegalovirus (CMV) infection prevention in adult cord blood transplantation (CBT) recipients & does not prevent emergence of CMV-specific donor-derived immunity
    Meeting Abstract

    Politikos, I.; Lau, C.; Devlin, S. M.; Naputo, K.; Quach, S.; Chinapen, S.; Lin, A.; Papadopoulos, E. B.; Perales, M. A.; Shah, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization
    Meeting Abstract

    Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Impact of HHV-6 in recipients of ex vivo T-cell depleted hematopoietic cell transplant
    Meeting Abstract

    Lee, Y. J.; Su, Y.; Tamari, R.; Jakubowski, A. A.; Giralt, S. A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Economic burden of cytomegalovirus infection in CMV-seropositive hematopoietic stem cell transplant recipients managed with pre-emptive therapy: A single center experience
    Meeting Abstract

    Fang, J.; Zavras, P. D.; Su, Y.; Raval, A.; Tang, Y.; Perales, M.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Toxicities of CMV preemptive therapy in the first 100 days after allogeneic hematopoietic cell transplantation (HCT): A real-world study at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Zavras, P. D.; Su, Y.; Gupta, N.; Maloy, M. A.; Fang, J.; Perales, M. A.; Giralt, S. A.; Jakubowski, A. A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Meeting Abstract

    Maples, K. T.; Maloy, M. A.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir prophylaxis demonstrates high efficacy in adult cytomegalovirus (CMV) seropositive cord blood transplant (CBT) recipients: A comparison with pre-letermovir era CBT controls
    Meeting Abstract

    Lau, C.; Politikos, I.; Maloy, M. A.; Naputo, K.; Afuye, A.; Devlin, S. M.; Bhatt, V.; Giralt, S. A.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • High survival rates in adult allogenic hematopoietic cell transplant patients with adenovirus viremia treated with brincidofovir
    Meeting Abstract

    Richards, R.; Cheteyan, L.; Papadopoulos, E. B.; Jakubowski, A. A.; Castro-Malaspina, H.; Papanicolaou, G. A.; Lee, Y. J.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Analysis of cytomegalovirus (CMV) infections in the first 180 days in adult sero-positive cord blood transplantation (CBT) recipients reveals high infection rates and treatment burden
    Meeting Abstract

    Lau, C.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Bhatt, V.; Dahi, P. B.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save